COMMUNIQUÉ DE PRESSE publié le 17/01/2024 à 08:00, il y a 2 années 1 mois Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Publié le 18/02/2026 à 13:45, il y a 3 heures 17 minutes NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Publié le 18/02/2026 à 11:00, il y a 6 heures 1 minute Mise à disposition des documents préparatoires à l'AG
Publié le 18/02/2026 à 08:07, il y a 8 heures 55 minutes TERACT - Modification du calendrier financier
Publié le 18/02/2026 à 15:15, il y a 1 heure 47 minutes Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Publié le 18/02/2026 à 15:00, il y a 2 heures 2 minutes Jaguar Health Announces a Special One-time Stock Dividend
Publié le 18/02/2026 à 14:25, il y a 2 heures 37 minutes Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Publié le 18/02/2026 à 14:00, il y a 3 heures 2 minutes Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Publié le 18/02/2026 à 14:00, il y a 3 heures 2 minutes Datametrex Receives $1M Order from Fortune 500 Client
Publié le 18/02/2026 à 15:50, il y a 1 heure 12 minutes CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Publié le 18/02/2026 à 15:48, il y a 1 heure 14 minutes Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Publié le 18/02/2026 à 15:47, il y a 1 heure 15 minutes Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Publié le 18/02/2026 à 15:46, il y a 1 heure 16 minutes Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Publié le 18/02/2026 à 15:44, il y a 1 heure 18 minutes Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC